LifeVantage (LFVN) Short Interest Ratio & Short Volume $15.09 -0.19 (-1.24%) (As of 11:38 AM ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends LifeVantage Short Interest DataLifeVantage (LFVN) has a short interest of 221,400 shares, representing 2.22% of the float (the number of shares available for trading by the public). This marks a -14.35% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.1, indicating that it would take 2.1 days of the average trading volume of 62,785 shares to cover all short positions.Current Short Interest221,400 sharesPrevious Short Interest258,500 sharesChange Vs. Previous Month-14.35%Dollar Volume Sold Short$3.06 millionShort Interest Ratio2.1 Days to CoverLast Record DateNovember 15, 2024Outstanding Shares12,520,000 sharesFloat Size9,990,000 sharesShort Percent of Float2.22%Today's Trading Volume38,021 sharesAverage Trading Volume62,785 sharesToday's Volume Vs. Average61% Short Selling LifeVantage? Sign up to receive the latest short interest report for LifeVantage and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLFVN Short Interest Over TimeLFVN Days to Cover Over TimeLFVN Percentage of Float Shorted Over Time Ad Chaikin AnalyticsBofA is watching for a market topU.S. tech stocks have soared so high for so long that they're no longer just minting new millionaires... They're minting new billionaires. The number of American billionaires has skyrocketed over last year – their wealth hitting a record $12.1 trillion – thanks to the Nasdaq's extraordinary outperformance. But now, after two years of near-vertical gains...New warnings out of Wall Street suggest that the winds are about to change. LifeVantage Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/15/2024221,400 shares $3.06 million -14.4%2.2%2.1 $13.83 10/31/2024258,500 shares $3.16 million +11.9%2.6%2.6 $12.22 10/15/2024231,100 shares $2.75 million +13.8%2.3%2.5 $11.92 9/30/2024203,000 shares $2.45 million +4.8%2.1%2.3 $12.08 9/15/2024193,700 shares $2.03 million +52.2%2.0%2.4 $10.50 8/31/2024127,300 shares $1.01 million -11.8%1.3%1.8 $7.96 Get the Latest News and Ratings for LFVN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for LifeVantage and its competitors with MarketBeat's FREE daily newsletter. 8/15/2024144,400 shares $1.18 million +45.9%1.4%2.5 $8.18 7/31/202499,000 shares $809,820.00 +24.5%1.0%1.6 $8.18 7/15/202479,500 shares $497,670.00 +3.1%0.8%1.8 $6.26 6/30/202477,100 shares $494,982.00 -8.3%0.8%1.8 $6.42 6/15/202484,100 shares $580,290.00 -11.2%0.8%2.1 $6.90 5/31/202494,700 shares $720,667.00 +20.5%0.9%2.4 $7.61 5/15/202478,600 shares $562,776.00 -0.3%0.8%2 $7.16 4/30/202478,800 shares $480,680.00 +16.6%0.8%2.2 $6.10 4/15/202467,600 shares $388,700.00 +6.1%0.7%1.9 $5.75 3/31/202463,700 shares $385,385.00 -21.7%0.6%1.8 $6.05 3/15/202481,400 shares $569,800.00 -16.5%0.8%2.3 $7.00 2/29/202497,500 shares $664,950.00 +12.6%1.0%2.7 $6.82 2/15/202486,600 shares $562,034.00 +4.7%0.9%2.4 $6.49 1/31/202482,700 shares $439,137.00 -18.8%0.8%1.8 $5.31 1/15/2024101,900 shares $588,982.00 -5.1%1.0%1.8 $5.78 12/31/2023107,400 shares $644,400.00 -15.2%1.1%1.8 $6.00 12/15/2023126,600 shares $792,516.00 -6.0%1.3%2.2 $6.26 11/30/2023134,700 shares $849,957.00 +40.9%1.3%2.1 $6.31 11/15/202395,600 shares $448,364.00 -40.3%1.0%0.9 $4.69 10/31/2023160,000 shares $1.20 million +46.4%1.6%1.7 $7.51 10/15/2023109,300 shares $765,100.00 +3.8%1.1%1.4 $7.00 9/30/2023105,300 shares $679,185.00 -4.8%1.0%1.4 $6.45 9/15/2023110,600 shares $721,112.00 -23.1%1.1%1.5 $6.52 8/31/2023143,800 shares $1.06 million +226.8%1.4%2 $7.40 8/15/202344,000 shares $227,920.00 -9.8%0.4%1.3 $5.18 7/31/202348,800 shares $246,928.00 +1.2%0.5%1.5 $5.06 7/15/202348,200 shares $215,454.00 +6.6%0.4%1.5 $4.47 6/30/202345,200 shares $196,620.00 -17.7%0.4%1.5 $4.35 6/15/202354,900 shares $288,774.00 +24.8%0.5%1.9 $5.26 5/31/202344,000 shares $205,040.00 +10.3%0.4%1.8 $4.66 5/15/202339,900 shares $174,363.00 +19.1%0.4%2.3 $4.37 4/30/202333,500 shares $110,550.00 +3.4%0.3%2.4 $3.30 4/15/202332,400 shares $108,864.00 +0.3%0.3%2.4 $3.36 3/31/202332,300 shares $115,957.00 -12.7%0.3%2.2 $3.59Media Is Mocking Elon, But Wait Until They See This Demo (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. 3/15/202337,000 shares $120,620.00 +2.5%0.3%2.1 $3.26 2/28/202336,100 shares $140,068.00 +0.3%0.3%1.8 $3.88 2/15/202336,000 shares $143,280.00 -0.8%0.3%1.6 $3.98 1/31/202336,300 shares $145,200.00 -0.6%0.3%1.4 $4.00 1/15/202336,500 shares $141,985.00 -17.2%0.3%1.3 $3.89 12/30/202244,100 shares $164,052.00 +8.9%0.4%1.4 $3.72 12/15/202240,500 shares $155,925.00 +6.9%0.4%1.4 $3.85 11/30/202237,900 shares $141,746.00 -7.6%0.3%1.2 $3.74 11/15/202241,000 shares $159,900.00 +2.0%0.4%1.2 $3.90 10/31/202240,200 shares $162,006.00 -35.6%0.4%1.2 $4.03 10/15/202262,400 shares $237,120.00 +28.4%0.6%1.6 $3.80 9/30/202248,600 shares $182,250.00 +9.7%0.4%1.3 $3.75 9/15/202244,300 shares $173,213.00 -6.9%0.4%1.2 $3.91 8/31/202247,600 shares $189,448.00 +4.2%0.4%1.3 $3.98 8/15/202245,700 shares $192,854.00 +18.4%0.4%1.4 $4.22 7/31/202238,600 shares $164,050.00 +1.9%0.3%1.1 $4.25 7/15/202237,900 shares $158,422.00 -24.7%0.3%1.1 $4.18 6/30/202250,300 shares $218,805.00 +25.8%0.4%1.5 $4.35 6/15/202240,000 shares $173,600.00 -13.4%0.3%1.2 $4.34 5/31/202246,200 shares $189,882.00 +6.7%0.4%1.4 $4.11 5/15/202243,300 shares $175,365.00 +2.4%0.4%1.2 $4.05 4/30/202242,300 shares $164,970.00 +4.4%0.4%1 $3.90 4/15/202240,500 shares $187,110.00 -16.2%0.3%0.8 $4.62 3/31/202248,300 shares $229,908.00 -8.5%0.4%1 $4.76 3/15/202252,800 shares $254,496.00 -6.1%0.5%1 $4.82 2/28/202256,200 shares $313,596.00 +19.3%0.5%1 $5.58 2/15/202247,100 shares $251,043.00 -23.4%0.4%0.8 $5.33 1/31/202261,500 shares $395,445.00 -36.7%0.6%1.1 $6.43 1/15/202297,200 shares $635,688.00 +29.4%0.8%2 $6.54 12/31/202175,100 shares $474,632.00 -0.8%0.7%1.6 $6.32 12/15/202175,700 shares $507,190.00 -0.8%0.7%1.6 $6.70 11/30/202176,300 shares $490,609.00 -4.5%0.7%1.6 $6.43 11/15/202179,900 shares $572,084.00 -72.8%0.7%1.6 $7.16 10/29/2021293,300 shares $2.01 million -4.0%2.5%5.1 $6.85 10/15/2021305,400 shares $2.08 million +4.0%2.6%4.8 $6.82 9/30/2021293,800 shares $1.99 million -10.3%2.5%3.4 $6.77 9/15/2021327,700 shares $2.34 million +1.1%2.7%2.4 $7.15 8/31/2021324,300 shares $2.52 million +2.5%2.7%2.3 $7.77 8/13/2021316,500 shares $2.26 million -7.0%2.6%2.2 $7.14 7/30/2021340,300 shares $2.76 million +13.4%2.7%2.4 $8.12 7/15/2021300,200 shares $2.05 million +2.4%2.4%2 $6.84 6/30/2021293,200 shares $2.16 million -50.3%2.3%2.3 $7.35 6/15/2021590,200 shares $4.82 million -7.4%4.7%6.2 $8.16 5/28/2021637,200 shares $5.08 million -3.0%5.1%7.1 $7.97 5/14/2021656,900 shares $5.19 million +9.8%5.2%7 $7.90 4/30/2021598,400 shares $5.22 million +26.8%4.8%5.9 $8.72 4/15/2021472,000 shares $4.15 million -19.7%3.7%4.9 $8.79 3/31/2021587,800 shares $5.54 million -19.1%4.6%6.1 $9.43 3/15/2021726,500 shares $6.80 million -10.2%5.7%7.9 $9.36 2/26/2021809,400 shares $7.18 million +18.9%6.4%9.1 $8.87Media Is Mocking Elon, But Wait Until They See This Demo (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. 2/12/2021680,600 shares $6.21 million +0.7%5.3%7.6 $9.13 1/29/2021675,600 shares $6.06 million -7.0%5.3%7.9 $8.97 1/15/2021726,700 shares $6.85 million +0.9%5.7%9.6 $9.43 12/31/2020720,500 shares $6.74 million -8.3%5.6%9.6 $9.36 12/15/2020786,000 shares $8.71 million -0.8%6.1%11.1 $11.08 11/30/2020792,200 shares $9.00 million +21.0%6.2%11.3 $11.36 11/15/2020654,900 shares $7.30 million -15.2%5.1%8.9 $11.14 10/30/2020771,900 shares $8.82 million +30.9%6.0%11.1 $11.42 10/15/2020589,500 shares $7.79 million +1.8%4.6%9.2 $13.22 9/30/2020578,900 shares $6.99 million +4.5%4.5%9.7 $12.07 9/15/2020553,900 shares $7.57 million -5.5%4.3%8 $13.66 8/31/2020585,800 shares $8.80 million +3.5%4.5%8 $15.02 8/14/2020565,900 shares $7.45 million -2.3%4.3%7.5 $13.16 7/31/2020579,000 shares $7.43 million -2.0%4.4%7.7 $12.84 7/15/2020590,900 shares $7.91 million -3.3%4.5%6 $13.38 6/30/2020610,900 shares $7.90 million +5.8%4.7%6 $12.93 6/15/2020577,500 shares $8.36 million -6.2%4.4%5.7 $14.48 5/29/2020615,700 shares $9.43 million +1.0%4.7%5.7 $15.31 5/15/2020609,600 shares $8.52 million -5.9%4.7%5.6 $13.98 4/30/2020647,600 shares $10.04 million +0.5%5.0%6 $15.50 4/15/2020644,100 shares $7.68 million -2.8%5.0%6.4 $11.92 3/31/2020662,900 shares $8.66 million -2.9%5.1%6.5 $13.06 3/13/2020682,900 shares $8.09 million +1.9%5.2%7.4 $11.84 2/28/2020670,100 shares $6.62 million +2.4%5.1%7.6 $9.88 2/14/2020654,200 shares $7.81 million +9.2%5.0%7.8 $11.94 1/31/2020599,100 shares $8.26 million -10.2%4.6%7.3 $13.79 1/15/2020667,000 shares $10.56 million -10.9%5.3%8.4 $15.83 12/31/2019748,500 shares $11.41 million -9.1%6.0%8.8 $15.25 LFVN Short Interest - Frequently Asked Questions What is LifeVantage's current short interest? Short interest is the volume of LifeVantage shares that have been sold short but have not yet been closed out or covered. As of November 15th, investors have sold 221,400 shares of LFVN short. 2.22% of LifeVantage's shares are currently sold short. Learn More on LifeVantage's current short interest. What is a good short interest ratio for LifeVantage? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LFVN shares currently have a short interest ratio of 2.0. Learn More on LifeVantage's short interest ratio. Which institutional investors are shorting LifeVantage? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of LifeVantage: Belvedere Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for LifeVantage? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.22% of LifeVantage's floating shares are currently sold short. Is LifeVantage's short interest increasing or decreasing? LifeVantage saw a decrease in short interest in the month of November. As of November 15th, there was short interest totaling 221,400 shares, a decrease of 14.4% from the previous total of 258,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is LifeVantage's float size? LifeVantage currently has issued a total of 12,520,000 shares. Some of LifeVantage's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. LifeVantage currently has a public float of 9,990,000 shares. How does LifeVantage's short interest compare to its competitors? 2.22% of LifeVantage's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to LifeVantage: Entrada Therapeutics, Inc. (7.42%), Tectonic Therapeutic (5.64%), Dianthus Therapeutics, Inc. (26.33%), AnaptysBio, Inc. (25.83%), ORIC Pharmaceuticals, Inc. (16.24%), Arbutus Biopharma Co. (3.20%), Tourmaline Bio, Inc. (11.04%), Esperion Therapeutics, Inc. (16.02%), Taysha Gene Therapies, Inc. (7.69%), Pharvaris (1.08%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.85 billion), Charter Communications, Inc. ($4.81 billion), International Paper ($2.96 billion), Cencora, Inc. ($2.40 billion), Paychex, Inc. ($2.38 billion), Lululemon Athletica Inc. ($2.05 billion), SoFi Technologies, Inc. ($2.03 billion), Live Nation Entertainment, Inc. ($1.93 billion), Onsemi ($1.82 billion), and Tractor Supply ($1.65 billion). View all of the most shorted stocks. What does it mean to sell short LifeVantage stock? Short selling LFVN is an investing strategy that aims to generate trading profit from LifeVantage as its price is falling. LFVN shares are trading down $0.19 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against LifeVantage? A short squeeze for LifeVantage occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LFVN, which in turn drives the price of the stock up even further. How often is LifeVantage's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LFVN, twice per month. The most recent reporting period available is November, 15 2024. More Short Interest Resources from MarketBeat Related Companies Entrada Therapeutics Short Squeeze Tectonic Therapeutic Short Squeeze Dianthus Therapeutics Short Squeeze AnaptysBio Short Squeeze ORIC Pharmaceuticals Short Squeeze Arbutus Biopharma Short Squeeze Tourmaline Bio Short Squeeze Esperion Therapeutics Short Squeeze Taysha Gene Therapies Short Squeeze Pharvaris Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LFVN) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeVantage Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeVantage With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.